Bernard Escudier. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/adverse effectsAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsBevacizumabCarcinoma, Renal Cell/drug therapyClinical Trials, Phase III as TopicDrug Therapy, CombinationHumansInterferons/administration & dosageInterferons/adverse effectsKidney Neoplasms/drug therapy
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBevacizumabInterferons
Year: 2008 PMID: 18548253 DOI: 10.1007/s00345-008-0280-1
Source DB: PubMed Journal: World J Urol ISSN: 0724-4983 Impact factor: 4.226